Evidence map›Paper›PMID 34698281›Full record

ArticleVision (Basel, Switzerland)2021

Impact of

Natasha Spiteri, Nino Hirnschall, Katherine van Bysterveldt, Alec Lin Hou, Gregory Moloney, Matthew Ball, Andrea L Vincent

Open access · goldAbstract read
In one paragraph

Article in Vision (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 4 countries.

Natasha SpiteriDepartment of Ophthalmology, Countess of Chester Hospital, Liverpool Road, Chester, Cheshire CH2 1UL, UK.
Nino HirnschallVIROS-Vienna Institute for Research in Ocular Surgery, a Karl Landsteiner Institute, Hanusch Hospital, Heinrich-Collin-Straße 30, 1140 Vienna, Austria.
Katherine van BysterveldtDepartment of Ophthalmology, Faculty of Medical and Health Science, New Zealand National Eye Centre, University of Auckland, Auckland 1142, New Zealand.
Alec Lin HouDepartment of Ophthalmology, Faculty of Medical and Health Science, New Zealand National Eye Centre, University of Auckland, Auckland 1142, New Zealand.
Gregory MoloneySydney Eye Hospital, 8, Macquarie Street, Sydney, NSW 2000, Australia.
Matthew BallSydney Eye Hospital, 8, Macquarie Street, Sydney, NSW 2000, Australia.
Andrea L VincentDepartment of Ophthalmology, Faculty of Medical and Health Science, New Zealand National Eye Centre, University of Auckland, Auckland 1142, New Zealand.ORCID 0000-0002-4185-3267
University of Auckland · NZHanusch Hospital · ATSydney Hospital · AUThe University of Sydney · AUUniversity of Liverpool · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo investigate whether Fuchs endothelial corneal dystrophy (FECD) genotype, specifically transcription factor 4 (

methodsThis prospective, interventional trial was conducted on consecutive FECD patients undergoing DSO. Genetic analysis using patients' saliva was performed to assess the extent of CTG expansion using short tandem repeat analysis, corroborated gel electrophoresis and Sanger sequencing. Polymerase chain reaction and bidirectional Sanger sequencing was undertaken. Partial least square regression and logistic regression modelling was used to evaluate the predictive power of

resultsOf 11 eyes of 11 patients, 8 showed complete corneal clearance. For these 8 patients, mean

conclusionWhilst it was not possible to predict time to corneal clearance based on CTG repeats, there is a significant correlation between allele repeats and achievement of corneal clearance.

Indexed as

descemetorhexisdescemet stripping only (DSO)fuchs endothelial corneal dystrophyTCF4 repeat

Identifiers

PMID34698281
PMCPMC8544680
OpenAlexW3203438641

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.